background
base
recent
vitro
data
test
hypothesi
microarray
express
profil
use
diagnos
sepsi
distinguish
vivo
steril
infecti
caus
system
inflamm
studi
design
exploratori
studi
conduct
use
spleen
septic
patient
mice
abdomin
sepsi
seven
patient
sepsi
injuri
identifi
retrospect
compar
six
injur
patient
male
mice
subject
cecal
ligat
punctur
ip
lipopolysaccharid
control
mice
sham
laparotomi
inject
ip
salin
respect
sepsi
classif
model
creat
test
blood
sampl
septic
mice
accuraci
sepsi
predict
obtain
use
crossvalid
gene
express
data
human
spleen
sampl
mous
spleen
sampl
blood
studi
classifi
construct
use
data
train
data
set
microarray
error
rate
classifi
estim
seven
deidentifi
microarray
subsequ
crossvalid
blood
microarray
estim
classif
accuraci
sepsi
human
spleen
mous
spleen
mous
blood
estim
base
nest
crossvalid
list
gene
substanti
chang
express
studi
control
group
use
identifi
nine
mous
common
inflammatori
respons
gene
six
map
singl
pathway
use
contemporari
pathway
analysi
tool
conclus
sepsi
induc
chang
mous
leukocyt
gene
express
use
diagnos
sepsi
apart
system
inflamm
j
coll
surg
american
colleg
surgeon
compet
interest
declar
design
conduct
studi
collect
manag
analysi
interpret
data
support
part
jpc
jpc
rsh
american
colleg
surgeon
georg
ha
clow
jr
memori
research
career
develop
award
jpc
fund
agenc
conduct
portion
studi
contribut
manuscript
prepar
td
djm
hd
employe
partek
incorpor
softwar
compani
expertis
microarray
analys
exampl
nest
crossvalid
genechip
analys
perform
use
partek
softwar
describ
herein
monetari
contribut
mr
larami
current
affili
incid
sepsi
number
sepsisrel
death
increas
substanti
cost
billion
annual
us
report
recent
cornerston
success
therapi
earli
accur
diagnosi
coupl
erad
sourc
infect
appropri
antibiot
therapi
unfortun
effort
identifi
specif
sensit
diagnost
marker
sepsi
met
limit
success
diagnosi
sepsi
icu
especi
challeng
frequent
difficult
distinguish
system
inflamm
system
infect
clinician
unabl
identifi
pathogen
respons
sepsi
patient
determin
whether
patient
respond
antibiot
therapi
tradit
mean
identifi
organ
respons
bacteri
infect
nonspecif
gram
stain
slow
cultur
insensit
gram
stain
cultur
compel
evid
effort
identifi
clinic
import
biomark
sepsi
prove
success
ultim
especi
given
recent
success
highthroughput
genom
technolog
field
face
diagnost
challeng
eg
leukemia
breast
colon
cancer
molecular
classif
strategi
involv
search
express
pattern
subset
gene
tissu
known
phenotyp
train
data
set
construct
predict
rule
use
biomark
gene
predict
phenotyp
new
sampl
test
data
set
studi
appli
genomewid
technolog
inflamm
sepsi
anim
model
patient
underway
review
recent
report
suggest
genomewid
profil
gene
express
hold
promis
molecular
diagnost
tool
capabl
gener
profil
leukocyt
sensit
specif
time
pathogen
detect
despit
provoc
vitro
find
report
use
microarray
studi
sepsi
vivo
report
indic
transcript
respons
polymicrobi
sepsi
organspecif
mice
rat
report
use
microarray
make
diagnosi
sepsi
although
recent
report
suggest
feasibl
patient
hypothes
leukocyt
gene
express
profil
obtain
use
dna
microarray
could
use
predict
septic
state
particular
distinguish
steril
infecti
sourc
system
inflamm
common
conundrum
care
critic
ill
injur
tissu
sampl
septic
patient
clinic
relev
mous
model
sepsi
test
use
investig
protocol
approv
washington
univers
human
studi
committe
inform
consent
obtain
collect
sampl
splenic
tissu
intraop
immedi
postmortem
describ
previous
seven
specimen
express
profil
chosen
retrospect
patient
injuri
trauma
oper
complic
sepsi
organ
dysfunct
sepsi
group
compar
six
ageand
gendermatch
control
specimen
patient
injuri
trauma
requir
splenectomi
injuri
group
total
patient
spleen
sampl
collect
care
use
laboratori
anim
conduct
accord
protocol
approv
washington
univers
anim
studi
committe
sevento
nineweekold
male
mice
purchas
harlan
inc
allow
acclimat
least
week
male
mice
use
avoid
confound
effect
femal
estrou
cycl
wellcharacter
sexual
dimorph
adapt
respons
cecal
ligat
punctur
clp
seven
experiment
group
design
make
classif
difficult
reflect
clinic
import
distinct
relev
care
icu
patient
lethal
abdomin
inflamm
steril
sourc
lethal
abdomin
infect
antibiotictr
abdomin
infect
mice
assign
seven
treatment
list
tabl
group
death
control
sick
substanti
associ
mortal
steril
infecti
caus
system
inflamm
normal
anim
untreat
previous
report
protocol
use
perform
clp
sham
laparotomi
ceca
anim
punctur
twice
use
needl
clp
other
punctur
use
needl
produc
milder
sepsi
caus
much
lower
mortal
mild
clp
anim
laparotomi
cecal
manipul
without
ligat
punctur
includ
sham
laparotomi
group
sham
anoth
group
anim
clp
treatment
standard
antibiot
regimen
mous
abdomin
sepsi
ip
ceftriaxon
mgkg
metronidazol
mgkg
deliv
hour
clp
clp
antibiot
group
induc
sever
system
inflamm
without
infect
ip
inject
escherichia
coli
lipopolysaccharid
lp
serotyp
mgkg
sigma
inc
perform
lp
group
dose
lp
mgkg
use
reliabl
produc
death
sever
day
anim
smaller
dose
pilot
experi
tend
produc
morbid
without
mortal
mice
inject
ip
abbrevi
acronym
clp
cecal
ligat
punctur
fdr
fals
discoveri
rate
est
express
sequenc
tag
ip
intraperiton
lp
lipopolysaccharid
pca
princip
compon
analysi
normal
salin
vehicl
salin
group
act
concurr
control
group
lp
treatment
censu
surviv
mice
record
interv
day
separ
cohort
mice
sacrif
hour
injuri
cervic
disloc
halothan
gener
anesthesia
time
point
injuri
chosen
pilot
experi
show
abil
distinguish
spleen
express
profil
greater
hour
hour
injuri
whole
spleen
tissu
eight
clp
eight
sham
mice
harvest
flashfrozen
liquid
nitrogen
store
anoth
cohort
anim
intracardiac
blood
eight
anim
per
group
pool
use
paxgen
blood
rna
system
deriv
total
rna
whole
blood
preanalytix
gmbh
genechip
blood
seven
group
prepar
total
mous
blood
genechip
anim
genechip
train
data
set
genechip
test
deidentifi
data
set
whole
blood
collect
autom
white
blood
cell
count
eight
anim
group
two
replic
run
perform
sampl
concurr
control
anim
hemavet
multispeci
hematolog
analyz
cdc
technolog
provid
count
autom
differenti
data
express
mean
sem
total
rna
human
mous
spleen
extract
per
trizol
protocol
life
technolog
inc
total
rna
mous
blood
extract
use
paxgen
kit
recommend
manufactur
crna
target
genechip
hybrid
prepar
total
rna
use
protocol
recommend
affymetrix
inc
human
spleen
crna
hybrid
human
fulllength
genechip
approxim
probe
set
mous
spleen
blood
crna
hybrid
genechip
approxim
probe
set
fluoresc
hybrid
signal
detect
use
genearray
scanner
hewlettpackard
inc
washington
univers
alvin
j
siteman
cancer
center
prospect
mous
cohort
genechip
scanner
affymetrix
data
discuss
public
deposit
ncbi
gene
express
omnibu
geo
http
wwwncbinlmnihgov
geo
access
geo
seri
access
number
test
differenti
express
class
predict
pathway
analysi
express
valu
calcul
genechipcel
file
use
dna
chip
analyz
softwar
version
default
set
perfect
match
probe
use
princip
compon
analysi
pca
use
visual
explor
global
effect
genomewid
trend
unexpect
effect
outlier
express
data
partek
softwar
differenti
express
gene
identifi
use
mixedmodel
anova
linear
contrast
next
determin
whether
possibl
accur
distinguish
tissu
sampl
result
model
steril
system
inflamm
model
system
infect
human
spleen
mous
spleen
mous
blood
produc
unbias
estim
predict
accuraci
also
optim
set
predictor
gene
classifi
type
classifi
paramet
use
twolevel
nest
crossvalid
procedur
produc
predict
estim
bias
gene
classifi
paramet
select
procedur
make
use
outer
crossvalid
produc
estim
accuraci
inner
crossvalid
perform
classifi
gene
select
class
predict
compar
knearest
neighbor
nearest
centroid
linear
quadrat
discrimin
analysi
classifi
two
complementari
program
use
queri
regulatori
network
pathwayassist
ariadn
genom
pathway
analysi
ingenu
system
pathwayassist
pathway
analysi
use
publish
literatur
publicli
avail
databas
identifi
relationship
gene
small
molecul
object
inform
turn
use
map
de
novo
put
interact
network
given
list
input
gene
surviv
data
calcul
use
kaplanmei
method
surviv
curv
compar
use
logrank
test
prism
graphpad
softwar
inc
cbc
cell
differenti
data
analyz
oneway
anova
use
tukeykram
posttest
correct
multipl
comparison
prism
modifi
multipl
organ
dysfunct
syndrom
mod
score
report
mean
sem
analyz
use
mannwhitney
u
test
nonparametr
data
prism
signific
chang
mous
blood
rel
rna
abund
measur
across
seven
group
use
twoway
anova
effect
treatment
batch
time
analysi
stepup
fals
discoveri
rate
fdr
use
identifi
subset
discrimin
gene
treatment
effect
visual
use
pca
pairwis
group
comparison
across
mous
blood
twoway
anova
effect
treatment
batch
use
batch
effect
spleen
oneway
anova
use
fdr
appli
raw
p
valu
pairwis
comparison
give
list
inform
gene
comparison
characterist
patient
sampl
found
tabl
none
injuri
control
patient
posit
cultur
sign
infect
sepsi
time
sampl
collect
one
recov
unev
splenectomi
contrast
sepsi
patient
posit
bacteri
fungal
cultur
obviou
sign
infect
pu
necrot
fasciiti
complic
sepsisinduc
organ
dysfunct
time
oper
modifi
mod
score
p
versu
injuri
dna
chip
analyz
hybrid
signal
analysi
use
default
filter
flag
human
genechip
statist
outlier
probe
pair
express
valu
calcul
statist
outlier
suggest
unreli
hybrid
signal
sampl
patient
omit
addit
analysi
pca
use
explor
differ
gene
express
gene
across
remain
microarray
demonstr
consider
differ
sepsi
injuri
class
data
shown
consist
larg
varianc
express
observ
across
subject
gene
identifi
differenti
express
two
class
use
fdr
estim
sepsi
class
predict
accuraci
among
sampl
leaveonesampleout
nest
crossvalid
perform
averag
predict
accuraci
control
group
anim
salin
sham
normal
surviv
durat
experi
contrast
sick
anim
system
infect
clp
clp
antibiot
mild
clp
lp
exhibit
typic
sign
piloerect
anorexia
lethargi
follow
mortal
rate
respect
fig
absolut
white
blood
cell
count
vari
among
seven
experiment
group
p
particular
control
sick
anim
fig
differ
among
anim
steril
infecti
caus
system
inflamm
lp
clp
mild
clp
clp
antibiot
likewis
differ
cell
differenti
among
control
among
anim
steril
infecti
caus
system
inflamm
except
lp
versu
clp
antibiot
neutrophil
lymphocyt
p
mous
differenti
gene
express
dna
chip
analyz
hybrid
signal
analysi
flag
mous
blood
genechip
statist
outlier
one
salin
one
sham
genechip
train
data
set
mous
outlier
genechip
omit
addit
analysi
thirtythre
genechip
remain
mous
blood
data
set
pca
use
visual
treatment
differ
express
gene
blood
spleen
demonstr
batch
anyclp
treatment
effect
p
fig
appli
stringent
multipl
test
correct
bonferroni
p
valu
twoway
anova
identifi
small
set
gene
blood
differenti
express
seven
treatment
group
probe
set
correspond
gene
probe
set
lipocalin
appear
twice
tabl
pca
analysi
probe
set
reveal
seven
experiment
group
cluster
three
appar
phenotyp
fig
control
anim
lpstreat
anim
steril
sourc
system
inflamm
clp
treatment
sepsi
comparison
gene
express
across
group
gener
sever
inform
gene
list
fdr
indic
appar
increas
decreas
gene
express
induc
clp
lp
fig
use
mous
spleen
sampl
gene
express
analysi
abl
classifi
sampl
clp
sham
accuraci
estim
use
crossvalid
blood
data
experiment
design
dictat
first
four
replic
batch
use
train
classifi
best
classifi
train
train
sampl
batch
use
predict
seven
deidentifi
test
sampl
batch
seven
test
sampl
predict
correctli
anyclp
septic
versu
nonclp
also
perform
fivefold
leaveonebatchout
crossvalid
produc
overal
accuraci
estim
fig
predict
accuraci
differenti
lp
control
abil
predict
low
versu
high
mortal
clp
substanti
lower
obtain
final
mous
blood
classifi
leaveonebatchout
crossvalid
perform
purpos
classifi
select
sixtyfour
classifi
tie
best
predict
median
number
gene
classifi
gene
gene
show
chang
greater
twofold
major
alter
twofold
less
nine
gene
demonstr
increas
rna
abund
across
spleen
blood
across
clp
lp
fig
call
cluster
gene
common
inflammatori
respons
cluster
tabl
pathway
analysi
tool
also
use
put
list
biolog
function
context
one
gene
annot
associ
previous
gene
product
small
molecul
cellular
process
link
inflamm
fig
singl
express
sequenc
tag
est
complet
list
nine
gene
genechip
identifi
blast
search
identifi
sequenc
retrovir
search
ncbi
gene
express
omnibu
microarray
databas
show
rna
affymetrix
probe
set
increas
number
model
inflamm
anim
human
abil
diagnos
sepsi
accur
would
allow
appropri
treatment
institut
earlier
therebi
improv
likelihood
surviv
hypothes
express
profil
could
distinguish
septic
nonsept
state
vivo
express
profil
could
defin
list
common
respond
gene
use
systemat
unbias
approach
recent
salin
sham
normal
appar
less
notabl
batch
effect
appear
explain
varianc
respect
pc
besid
show
substanti
differ
anyclp
nonclp
group
determin
ttest
pc
note
genechip
scanner
use
batch
differ
use
batch
latest
gener
one
explan
batch
differ
four
batch
report
use
microarray
technolog
vitro
indic
inflammatori
infecti
insult
produc
distinct
transcript
signatur
current
studi
first
examin
abil
microarray
gene
express
profil
distinguish
steril
infecti
caus
system
inflamm
vivo
examin
gene
express
profil
splenic
tissu
patient
injuri
versu
injuri
complic
sepsi
organ
dysfunct
differ
appar
gene
express
sepsi
injuri
control
phenotyp
use
construct
classifi
accuraci
estim
small
exploratori
clinic
studi
provid
bedsid
proof
feasibl
use
human
transcript
profil
model
septic
phenotyp
also
demonstr
larg
degre
varianc
gene
express
subject
technic
biolog
differ
control
varianc
move
bedsid
bench
perform
systemat
examin
diagnost
potenti
spleen
blood
gene
express
profil
inbr
mice
consist
human
data
spleen
sampl
mice
clp
exhibit
microarray
pattern
could
model
predict
septic
phenotyp
nest
crossvalid
accuraci
estim
sepsi
predict
use
mous
spleen
consider
better
found
use
human
spleen
like
mous
experiment
design
exploit
fresh
tissu
ident
age
gender
genotyp
across
subject
clinic
use
gene
express
analysi
use
splenic
tissu
sever
limit
explor
next
use
circul
blood
class
predict
mous
model
combin
accuraci
predict
anyclp
versu
nonclp
lp
versu
control
high
respect
accuraci
estim
distinguish
high
low
mortal
clp
group
clp
versu
mild
clp
clp
plu
antibiot
time
point
much
less
conclus
consist
pca
analysi
figur
sought
differ
appar
tabl
abx
antibiot
gene
express
across
seven
experiment
group
interestingli
sampl
cluster
outlier
clp
plu
antibiot
group
consist
effect
antibiot
chang
septic
phenotyp
toward
control
phenotyp
conclud
circul
blood
gene
express
profil
use
predict
clp
nonclp
phenotyp
prospect
cohort
particular
distinguish
control
lethal
endotoxicosi
lp
lethal
infect
clp
import
note
time
point
substanti
differ
lp
clp
group
clinic
present
complet
blood
count
microarray
analysi
could
make
diagnosi
sepsi
distinguish
steril
infecti
sourc
system
inflamm
clinic
criteria
white
blood
cell
count
could
frequent
occurr
icu
addit
differ
group
measur
absolut
foldchang
individu
gene
express
small
eg
final
model
blood
gene
alter
less
twofold
yet
chang
pattern
express
across
hundr
gene
robust
predictor
phenotyp
discov
chang
express
gener
inflammatori
septic
respons
use
intersect
gene
list
identifi
pairwis
group
comparison
fig
nine
gene
commonli
increas
valid
across
two
tissu
type
spleen
blood
two
insult
clp
lp
contrast
gene
commonli
decreas
given
list
nine
gene
base
chang
rel
rna
abund
across
number
cell
type
network
analysi
perform
serv
exploratori
tool
valid
silico
role
six
nine
gene
canon
pathway
inflamm
apoptosi
signal
transduct
inhibitor
dna
bind
calgranulin
b
interferon
regulatori
factor
lipocalin
formyl
peptid
receptorlik
tabl
sever
characterist
nine
common
inflammatori
respons
gene
notabl
inhibitor
dna
bind
requir
normal
mous
immun
develop
especi
lymph
node
peyer
patch
calgranulin
b
belong
recent
describ
group
proinflammatori
molecul
form
extracellular
complex
bind
activ
endotheli
cell
promot
chemotaxi
phagocyt
adhes
posit
feedback
manner
interferon
regulatori
factor
key
regulatori
monocyt
develop
essenti
differenti
monocyt
macrophag
lipocalin
secret
protein
undergo
transcript
induct
cytokin
withdraw
induc
leukocytespecif
apoptosi
lipocalin
transcript
translat
secret
induc
ligat
tolllik
receptor
leukocyt
secret
lipocalin
act
sequest
siderophor
therebi
limit
bacteri
growth
formyl
peptid
receptorlik
member
chemoattract
subfamili
g
protein
coupl
receptor
involv
control
leukocyt
migrat
two
annot
gene
list
network
neutrophil
granul
protein
serum
amyloid
also
associ
inflamm
cellular
defens
although
less
known
function
protein
interact
neutrophil
granul
protein
cystein
proteas
inhibitor
associ
myeloid
differenti
serum
amyloid
highdens
apolipoprotein
amyloid
made
hepatocyt
peripher
monocyt
macrophag
believ
function
retarget
transport
lipid
includ
cholesterol
dispos
toxin
function
ninth
gene
retrovir
speci
increas
number
differ
model
infect
inflamm
known
compar
common
inflammatori
respons
cluster
list
protein
recent
report
diagnos
intraamniot
infect
patient
anoth
mean
valid
import
nine
gene
protein
polypeptid
detect
studi
also
identifi
studi
specif
calgranulin
b
lipocalin
neutrophil
gelatinaseassoci
lipocalin
calgranulin
also
differenti
express
gene
blood
small
microarray
studi
compar
eight
septic
patient
four
surgic
control
without
system
inflamm
serum
amyloid
protein
identifi
plasma
proteom
biomark
patient
coronaviru
sever
ard
togeth
studi
support
hypothesi
group
common
inflammatori
respons
gene
use
novel
biomark
diagnos
inflamm
across
speci
tissu
differ
type
infect
organ
either
rna
protein
level
larg
degre
variat
nois
human
spleen
gene
express
individu
gene
survey
pass
fdr
filter
nevertheless
data
patient
prove
invalu
studi
immun
dysfunct
human
sepsi
provid
proofofprincipl
molecular
profil
human
lymphoid
tissu
could
use
distinguish
septic
nonsept
phenotyp
cellular
popul
mammalian
tissu
heterogen
use
microarray
profil
studi
cellular
respons
given
stimulu
must
understood
context
chang
cell
popul
substanti
limit
conclus
whole
spleen
data
given
report
other
sepsi
acceler
splenocyt
apoptosi
contrast
chang
blood
cellular
heterogen
measur
routin
although
clp
lp
stimuli
chang
absolut
wbc
cell
differenti
compar
control
among
four
group
sick
anim
cell
count
indistinguish
fig
mirror
clinic
situat
differenti
steril
lp
infecti
anyclp
sourc
system
inflamm
possibl
base
clinic
ground
cell
count
microarray
profil
discuss
success
make
distinct
mani
question
remain
unansw
optim
comput
method
identifi
robust
predictor
microarray
proteom
data
gene
protein
express
profil
use
diagnos
sepsi
anim
model
predict
gene
set
common
differ
type
infect
eg
gramposit
versu
gramneg
infect
diagnosi
made
marker
indic
respons
therapi
prognosi
suffici
preclin
preliminari
patient
data
justifi
test
hypothes
heterogen
express
profil
largescal
collabor
studi
requir
enrol
suffici
patient
identifi
robust
sepsi
marker
process
untangl
biolog
infect
inflamm
back
bedsideth
promis
molecular
profil
sepsi
diagnosi
conclus
vivo
data
corrobor
vitro
find
indic
microarray
analysi
hold
promis
mean
identifi
distinct
express
profil
molecular
fingerprint
diagnos
septic
phenotyp
human
spleen
data
join
recent
blood
data
septic
patient
serum
amniot
fluid
data
patient
intraamniot
fluid
infect
indic
transcriptom
proteom
studi
deliv
promis
novel
inflamm
diagnost
singl
inflamm
gene
calgranulin
detect
three
studi
either
rna
protein
level
data
uniqu
show
transcriptom
molecular
profil
distinguish
steril
infecti
caus
system
inflamm
make
diagnosi
sepsi
pro
spectiv
cohort
importantli
observ
magnitud
chang
gene
express
need
predict
septic
phenotyp
small
pattern
small
chang
express
predict
magnitud
singl
chang
other
report
recent
valid
clinic
protocol
blood
gene
express
profil
use
character
human
system
inflammatori
respons
data
present
suggest
protocol
extend
clinic
trial
test
efficaci
microarray
gene
express
profil
diagnos
human
sepsi
expect
studi
provid
new
insight
specif
pathogen
uniqu
perturb
physiolog
circul
leukocyt
host
success
mount
pathogenspecif
defens
mous
common
inflammatori
respons
cluster
nine
probe
set
red
gene
commonli
alter
regardless
tissu
insult
contemporari
pathway
analysi
tool
use
automat
creat
network
interact
among
nine
gene
base
previous
report
interact
literatur
eight
nine
probe
set
known
inflamm
gene
ninth
probe
set
express
sequenc
tag
network
valid
silico
six
gene
involv
canon
pathway
inflamm
apoptosi
regul
signal
transduct
